Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05029726 · ClinicalTrials.gov registry record · Phase 4
Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery
A Phase 4 study of Degenerative Disc Disease and Lumbar Spinal Stenosis, sponsored by John O'Toole.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT05029726 is a Phase 4 study of Degenerative Disc Disease and Lumbar Spinal Stenosis that is actively recruiting participants, run by John O'Toole. The registered enrollment target is 125 participants, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05029726, a Phase 4 study of Degenerative Disc Disease and Lumbar Spinal Stenosis, is actively recruiting participants, sponsored by John O'Toole.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
Opioid overuse is a widespread public health crisis in the United States with increasing rates of addiction and overdose deaths from prescription opioids. Reducing the need for opiate analgesics in the post-operative setting has become a high priority in minimizing long-term opioid use in surgical patients. This study will serve to demonstrate the efficacy of the addition of regional analgesic techniques in reducing post-operative opioid requirements in patients undergoing common lumbar spinal surgical procedures.
Conditions Studied
Interventions
- DRUG Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine
- DRUG normal saline
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2027-04-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05029726
The ClinicalTrials.gov registry entry for NCT05029726 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (25% lower). The listed sponsor is John O'Toole, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine is the first listed.
NCT05029726 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05029726 about?
NCT05029726 is a clinical study titled "Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery". Opioid overuse is a widespread public health crisis in the United States with increasing rates of addiction and overdose deaths from prescription opioids. Reducing the need for opiate analgesics in the post-operative setting has become a high priority in minimizing long-term opioid use in surgical p...
What is the current status of trial NCT05029726?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 125 participants. The study started on 2022-02-01. Estimated completion is 2027-04-30.
What conditions does trial NCT05029726 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Lumbar Spinal Stenosis, Degenerative Spondylolisthesis, Lumbar Spondylosis, Lumbar Disc Herniation.
What interventions are being tested in trial NCT05029726?
The interventions under investigation include: Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine (DRUG), normal saline (DRUG).
Who is sponsoring clinical trial NCT05029726?
This trial is sponsored by John O'Toole, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05029726 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
OssDsign® Spine Registry Study ("Propel")
RECRUITING
-
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
RECRUITING · Phase 3
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.